Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Via Bedeschi 22 , Flamma Chignolo (headquarters), Chignolo d'Isola (BG), 24040, IT
Award-winning FLAMMA is a family-owned CDMO built for today’s biotech innovators. We bring 75 years of chemistry excellence to GMP manufacturing of small-molecule API, NCE & RSMs. Our 5 cGMP sites (Italy 3 + China + USA; 1,300 m³) deliver a SECURE, RELIABLE supply chain with real chemistry in every partnership. Move fast. Partner with Flamma USA
Approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria.
By: Charlie Sternberg
Researchers are invited to submit proposals for innovative research projects aimed at uncovering the entangled microcircuits and molecular targets disrupted in anhedonia.
The Future of Oral Solids explores how innovation, advanced manufacturing, and integrated CDMO partnerships are reshaping the oral solid dosage (OSD) landscape, now and in the years ahead.
Released By Adare Pharma Solutions
Veeva to deliver next-gen customer engagement with agentic AI for Roche.
Plans an expansion of its flagship biologics manufacturing facility in Frederick and construction of a new facility in Gaithersburg.
Codis launches as a global CDMO specializing in spray drying, amorphous solid dispersions, and particle engineering, uniting Particle Dynamics and EUROAPI’s former Haverhill facility under one brand.
Released By Codis
Sentry’s foreign trade zone expertise helps pharmaceutical companies mitigate risks from tariffs and global trade volatility.
Released By Sentry BioPharma Services, Inc.
Underscores the facility’s dedication to upholding the highest standards of quality across operations.
A conversation with Upperton’s Director of Pharmaceutical Sciences
Released By Upperton
The transaction is expected to close in the first quarter of 2026.
This is the first and only subcutaneous immune checkpoint inhibitor in Europe that a health care provider can administer in one minute.
By: Rachel Klemovitch
Iglesias will lead global medical affairs for botensilimab (BOT) and balstilimab (BAL).
Marks a strategic milestone in Halozyme’s mission to expand its drug delivery technology offerings to biopharma companies.
Strengthens its peptide technology platform to meet the rapidly growing global demand for peptide-based therapeutics.
Expands the company’s nationwide network supporting cell and gene therapy (CGT) innovation.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
